Breast cancer markers

被引:36
作者
Giancotti, Vincenzo [1 ]
机构
[1] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy
关键词
breast cancer; markers; kinases;
D O I
10.1016/j.canlet.2006.01.035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review illustrates the relationships linking the ER and the ErbB family of receptor tyrosine kinases and their kinase pathways in breast cancer. The central role of the ER in activating tumour growth linked gene transcription as well as the cooperating nuclear co-factors very likely implicated in breast cancer tumourigenesis is discussed. The action of ErbB family members has been located upstream of the kinase pathways that begin at plasma membrane and end at the nucleus after complex interconnections with many factors, such as AP-1. The important role of MAPKs and PKB/Akt in cell survival and tumour proliferation is highlighted. Also other factors are discussed such as Fra-1 (a member of the AP-1 complex), E-cadherin (a tumour suppressor), and BRCA1 (another factor involved in tumour growth inhibition). Lactoferrin protein (characteristic of healthy tissues) and resistance proteins have also been briefly discussed. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 159
页数:15
相关论文
共 104 条
[31]   Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis [J].
Farago, M ;
Dominguez, I ;
Landesman-Bollag, E ;
Xu, X ;
Rosner, A ;
Cardiff, RD ;
Seldin, DC .
CANCER RESEARCH, 2005, 65 (13) :5792-5801
[32]   Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: The Austrian breast and colorectal cancer study group [J].
Filipits, M ;
Pohl, G ;
Rudas, M ;
Dietze, O ;
Lax, S ;
Grill, R ;
Pirker, R ;
Zielinski, CC ;
Hausmaninger, H ;
Kubista, E ;
Samonigg, H ;
Jakesz, R .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1161-1168
[33]   Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype [J].
Frasor, J ;
Danes, JM ;
Komm, B ;
Chang, KCN ;
Lyttle, CR ;
Katzenellenbogen, BS .
ENDOCRINOLOGY, 2003, 144 (10) :4562-4574
[34]  
Freedman O. C., 2005, Cancer Treatment Reviews, V31, P1, DOI 10.1016/j.ctrv.2004.09.008
[35]  
Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO
[36]  
2-S
[37]   ERE-independent ERα target genes differentially expressed in human breast tumors [J].
Glidewell-Kenney, C ;
Weiss, J ;
Lee, EJ ;
Pillai, S ;
Ishikawa, T ;
Ariazi, EA ;
Jameson, JL .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 245 (1-2) :53-59
[38]  
Goss PE, 2004, BREAST CANCER RES TR, V88, pS1
[39]  
Hajra KM, 2002, CANCER RES, V62, P1613
[40]   SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer [J].
Hu, Y ;
Zhang, SZ ;
Yu, JK ;
Liu, J ;
Zheng, S .
BREAST, 2005, 14 (04) :250-255